Vitalhub (TSE:VHI) Stock Gets Price Target Reduction from ATB Cormark Capital Markets

Vitalhub (TSE:VHI – Free Report) had its price objective reduced by ATB Cormark Capital Markets from C$12.00 to C$10.25 in a research note issued to investors on Monday,BayStreet reports. They currently have an outperform rating on the stock.

Separately, Canaccord Genuity Group set a C$15.00 price objective on Vitalhub and gave the company a “buy” rating in a report on Friday, August 28th. Eight analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of C$10.86.

Read Our Latest Report on VHI

Vitalhub Stock Performance

VHI opened at C$6.66 on Monday. Vitalhub has a 52-week low of C$6.46 and a 52-week high of C$9.77. The firm has a market capitalization of C$421.84 million, a PE ratio of 55.50, a PEG ratio of 1.18 and a beta of 1.37. The business’s 50-day simple moving average is C$7.49 and its 200 day simple moving average is C$7.55.

Vitalhub (TSE:VHI – Get Free Report) last posted its quarterly earnings results on Thursday, November 12th. The company reported C$0.04 earnings per share for the quarter. The firm had revenue of C$31.91 million during the quarter. Vitalhub had a return on equity of 4.03% and a net margin of 8.63%. On average, research analysts forecast that Vitalhub will post 0.23 earnings per share for the current year.

Key Stories Impacting Vitalhub

Investors following VHI have been watching these stories:

  • Positive Sentiment: Canaccord Genuity and Scotiabank are reported as maintaining or issuing Buy recommendations, indicating that both see potential upside despite the broader target reductions. Canaccord Genuity Buy report Scotiabank Buy report
  • Negative Sentiment: Multiple firms—including ATB Cormark, Canaccord, Stifel Nicolaus, Raymond James and National Bank Financial—cut their price targets for Vitalhub. Scotia and TD also issued more pessimistic price forecasts. Target cuts can weigh on sentiment by implying less expected upside, even when an analyst’s rating remains Buy. ATB Cormark target cut Analyst target cuts and fair value
  • Negative Sentiment: Royal Bank of Canada downgraded Vitalhub from “Moderate Buy” to “Hold,” signaling a less favorable view of the shares. RBC recommendation

About Vitalhub

(Get Free Report)

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.

See Also

Analyst Recommendations for Vitalhub (TSE:VHI)

Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.